Kien T. Tan
3F, No.345, Xinhu 2nd Rd, 114
Neihu, TPQ, Taiwan
Neihu, TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma.
Journal: Clinical & translational immunology
Published: March 25, 2023
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: January 18, 2023
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.
Journal: Targeted oncology
Published: April 26, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 11, 2022
Comprehensive assessment of actionable genomic alterations in primary colorectal carcinoma using targeted next-generation sequencing.
Journal: British journal of cancer
Published: February 23, 2022
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma.
Journal: Hepatology international
Published: January 17, 2022
Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.
Journal: Clinical and translational medicine
Published: May 26, 2021
Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic BRCA2 Mutation.
Journal: OncoTargets and therapy
Published: May 04, 2021
Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer.
Journal: Biomedical journal
Published: April 23, 2021
Transient Response of Olaparib on Pulmonary Artery Sarcoma Harboring Multiple Homologous Recombinant Repair Gene Alterations.
Journal: Journal of personalized medicine
Published: April 08, 2021
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: November 25, 2020
Last Updated: 09/26/2026